4th Department of Internal Medicine, Hippokration Hospital, School of Medicine, Aristotle University Thessaloniki, Greece
T Dimitroulas
Volume 34, Issue 3, September 2023
Sign in to download the Issue in PDF format.
1940646460
Mediterr J Rheumatol 2023;34(3):282-3
Article Links
Tofacitinib as a Promising Therapeutic Option in Refractory Autoimmune-Mediated Vascular and Sclera Inflammation
Abstract
This paper has no abstract.Cite this article as: Dimitroulas T. Tofacitinib as a Promising Therapeutic Option in Refractory Autoimmune-Mediated Vascular and Sclera Inflammation. Mediterr J Rheumatol 2023;34(3):282-3.
Article Submitted: 22 Sep 2023; Article Accepted: 24 Sep 2023; Available Online: 29 Sep 2023
This work is licensed under a Creative Commons Attribution 4.0 International License.
©2023 The Author(s).
